Gabapentin
Product Images NDC 45865-347

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 45865-347). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

D239baac-figure-01 (Gabapentin 300mg 1)

Chemical structure diagram of gabapentin showing a cyclohexane ring bonded to an amino group and a carboxymethyl group.*

FDA Label Image

D239baac-figure-02 (Gabapentin 300mg 2)

A line graph showing mean pain scores over 8 weeks comparing placebo and Gabapentin 3600 mg/day. The x-axis represents weeks, starting at baseline, with a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis shows pain scores from 0 to 10. Gabapentin demonstrates a significant reduction in pain scores compared to placebo throughout the study, with p-values less than 0.01 indicated.*

FDA Label Image

D239baac-figure-03 (Gabapentin 300mg 3)

A line graph depicting the mean pain score over seven weeks comparing placebo with Gabapentin dosed at 1800 mg/day and 2400 mg/day. The graph highlights a 3-week dose titration period followed by a 4-week fixed dose period, showing a decrease in pain scores for Gabapentin groups compared to placebo, with statistical significance indicated at p < 0.01.*

FDA Label Image

D239baac-figure-04 (Gabapentin 300mg 4)

A bar graph showing the percentage of responders at endpoint in two studies comparing placebo (PBO) and Gabapentin (GBP) at different doses (1800, 2400, 3600 mg). The graph indicates higher response percentages with Gabapentin across both studies, with statistical significance marked (p < 0.01 and p < 0.001). The y-axis represents the percentage of responders, and the x-axis distinguishes between study groups and doses.*

FDA Label Image

D239baac-figure-05 (Gabapentin 300mg 5)

A scatter plot chart showing percentage difference on the y-axis versus daily dose in mg on the x-axis (600, 900, 1200, 1800 mg). Three different studies labeled a, b, and c are represented by black, gray, and white squares, respectively, with corresponding data points illustrating variation in difference percentages at various daily doses.*

FDA Label Image

Bottle Of 30 (Gabapentin 300mg 6)

Gabapentin Capsules 300 mg label for a 30-count bottle, generic for Neurontin, from Medsource Pharmaceuticals. The label specifies each capsule contains 300 mg of gabapentin and includes the NDC number 45865-0347-30. The label has directions to take capsules daily with space for dosing instructions in English and Spanish.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.